Biogen Inc. buy hoffi69
Start price
08.05.12
/
50%
€101.61
Target price
23.10.12
€110.00
Performance (%)
7.22%
End price
23.10.12
€108.95
Summary
This prediction ended on 23.10.12 with a price of €108.95. The BUY prediction by hoffi69 finished with a performance of 7.22%. hoffi69 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | 1.160% | 1.160% | 3.309% | -44.027% |
| iShares Core DAX® | 1.732% | 4.638% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 3.304% | 0.517% | 5.422% | 113.046% |
| iShares Nikkei 225® | 2.342% | 0.972% | 15.333% | 47.267% |
| iShares S&P 500 | 2.357% | 0.872% | 3.125% | 68.687% |
Comments by hoffi69 for this prediction
In the thread Biogen Inc. diskutieren
Megatrend
Ähnlich wie Amgen steht auch Biogen grundsolide da.In den Megatrend molekularbiologisch/gentechnisch hergestellter Medikamente lohnt sich auch in unruhigen Börsenzeiten einzusteigen.Die Nachfrage wird weiter steigen.
(Vom Mitglied beendet)